SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APEN, HZNP, SESN
NEW YORK, Jan. 3, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Apollo Endosurgery, Inc. (NASDAQ: APEN)’s sale to Boston Scientific Corporation for $10.00 per share in cash. If you are an Apollo shareholder, click here to learn more about your legal rights and options.
Horizon Therapeutics plc (NASDAQ: HZNP)’s sale to Amgen Inc. for $116.50 in cash per share. If you are a Horizon shareholder, click here to learn more about your rights and options.
Sesen Bio, Inc. (NASDAQ: SESN)’s merger with Carisma Therapeutics Inc. Pre-merger Sesen Bio shareholders are expected to own approximately 41.7% of the combined company. If you are a Sesen Bio shareholder, click here to learn more about your rights and options.
Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email firstname.lastname@example.org or email@example.com.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Halper Sadeh LLC
Daniel Sadeh, Esq.
Zachary Halper, Esq.
View original content to download multimedia: https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-apen-hznp-sesn-301712326.html
SOURCE Halper Sadeh LLP